These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23912588)

  • 21. [Research advances in gene polymorphisms in biological pathways of drugs for asthma].
    Guo DD; Zheng XR
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Jun; 18(6):567-73. PubMed ID: 27324549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefit-risk assessment of long-acting beta2-agonists in asthma.
    Jackson CM; Lipworth B
    Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review on Pharmacogenetics and Pharmacogenomics Applied to the Study of Asthma.
    Sánchez-Martín A; García-Sánchez A; Isidoro-García M
    Methods Mol Biol; 2016; 1434():255-72. PubMed ID: 27300544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asthma genetics and personalised medicine.
    Meyers DA; Bleecker ER; Holloway JW; Holgate ST
    Lancet Respir Med; 2014 May; 2(5):405-15. PubMed ID: 24794577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.
    Sadatsafavi M; Lynd LD; Marra CA; FitzGerald JM
    Thorax; 2014 Apr; 69(4):328-34. PubMed ID: 24281327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
    Chung LP; Waterer G; Thompson PJ
    Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asthma pharmacogenetics and the development of genetic profiles for personalized medicine.
    Ortega VE; Meyers DA; Bleecker ER
    Pharmgenomics Pers Med; 2015; 8():9-22. PubMed ID: 25691813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetic approaches in the treatment of asthma.
    Sayers I; Hall IP
    Curr Allergy Asthma Rep; 2005 Mar; 5(2):101-8. PubMed ID: 15683609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
    Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
    Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiinflammatory effects of long-acting beta2-agonists in patients with asthma: a systematic review and metaanalysis.
    Sindi A; Todd DC; Nair P
    Chest; 2009 Jul; 136(1):145-154. PubMed ID: 19255288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacogenetics and pharmacogenomics of asthma therapy.
    Tse SM; Tantisira K; Weiss ST
    Pharmacogenomics J; 2011 Dec; 11(6):383-92. PubMed ID: 21987090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of combination inhaled corticosteroids and long acting beta agonists in the treatment of adult asthma.
    Mayers I ; Damant R
    Issues Emerg Health Technol; 2005 Jun; (68):1-4. PubMed ID: 15966131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.
    Slob EMA; Vijverberg SJH; Palmer CNA; Zazuli Z; Farzan N; Oliveri NMB; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
    Pediatr Allergy Immunol; 2018 Nov; 29(7):705-714. PubMed ID: 29992699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of pharmacogenomics in the current and future treatment of asthma.
    Morrow T
    J Manag Care Pharm; 2007; 13(6):497-505. PubMed ID: 17672811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma.
    Chung KF; Adcock IM
    Treat Respir Med; 2004; 3(5):279-89. PubMed ID: 15606218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
    Wechsler ME; Kunselman SJ; Chinchilli VM; Bleecker E; Boushey HA; Calhoun WJ; Ameredes BT; Castro M; Craig TJ; Denlinger L; Fahy JV; Jarjour N; Kazani S; Kim S; Kraft M; Lazarus SC; Lemanske RF; Markezich A; Martin RJ; Permaul P; Peters SP; Ramsdell J; Sorkness CA; Sutherland ER; Szefler SJ; Walter MJ; Wasserman SI; Israel E;
    Lancet; 2009 Nov; 374(9703):1754-64. PubMed ID: 19932356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.